Online first
Editorial
Published online: 2024-08-29
Statin discontinuation: How can we improve on the multiple pathways that contribute to suboptimal statin adherence?
Pubmed: 39240921
Abstract
Not available
References
- De Vera MA, Bhole V, Burns LC, et al. Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review. Br J Clin Pharmacol. 2014; 78(4): 684–698.
- Munkhaugen J, Sverre E, Otterstad JE, et al. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients. Eur J Prev Cardiol. 2017; 24(9): 981–989.
- Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013; 34(38): 2940–2948.
- De Backer G, Jankowski P, Kotseva K, et al. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries. Atherosclerosis. 2019; 285: 135–146.
- Nowowiejska-Wiewióra A, Wita K, Mędrala Z, et al. Dyslipidemia treatment and attainment of LDL-cholesterol treatment goals in patients participating in the Managed Care for Acute Myocardial Infarction Survivors program. Kardiol Pol. 2023; 81(4): 359–365.
- Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42(34): 3227–3337.
- Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J. 2020; 41(1): 111–188.
- Mannsverk J, Wilsgaard T, Mathiesen EB, et al. Trends in modifiable risk factors are associated with declining incidence of hospitalized and nonhospitalized acute coronary heart disease in a population. Circulation. 2016; 133(1): 74–81.
- Sagan A, Rogala M, Buszman PP, et al. Improved coordination of care after acute myocardial infarction in Poland since 2017: Promising early results. Health Policy. 2021; 125(5): 587–592.
- Kardas P, Kwiatek A, Włodarczyk P, et al. Is the KOS-Zawał coordinated care program effective in reducing long-term cardiovascular risk in coronary artery disease patients in Poland? Insights from analysis of statin persistence in a nationwide cohort. Pol Heart J. 2024 [Epub ahead of print].
- Kolarczyk-Haczyk A, Konopko M, Mazur M, et al. Long-term outcomes of the Coordinated Care Program in Patients after Myocardial Infarction (KOS-MI). Kardiol Pol. 2023; 81(6): 587–596.
- Anderson LJ, Nuckols TK, Coles C, et al. A systematic overview of systematic reviews evaluating medication adherence interventions. Am J Health Syst Pharm. 2020; 77(2): 138–147.
- van Driel ML, Morledge MD, Ulep R, et al. Interventions to improve adherence to lipid-lowering medication. Cochrane Database Syst Rev. 2016; 12(12): CD004371.
- Howard JP, Wood FA, Finegold JA, et al. Side effect patterns in a crossover trial of statin, placebo, and no treatment. J Am Coll Cardiol. 2021; 78(12): 1210–1222.
